On this week’s Tech Nation, Moira speaks with

the committed people who lead the biotech industry. Physician-entrepreneur Dr. Jeremy Levin chairs BIO, the Biotechnology Innovation Organization, and also works on the rare disease Angelman Syndrome at Ovid Therapeutics. Jim Greenwood, the CEO of BIO, asks “What’s the right thing to do?” about the price of drugs and everyday people. While BIO Vice Chair, Paul Hastings, is also the CEO of Nkarta Therapeutics. With Senior Vice President, Nadir Mahmood, they’re working with Natural Killer cells to fight cancer.